An open letter to all Canadian Periodontists.
Perry
R
R
Knowell Therapeutic Technologies, Toronto, Ont.
D000328:Adult; D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D001419:Bacteria / Q000302:isolation & purification; D001587:Benzoylarginine-2-Naphthylamide; D002170:Canada; D003131:Combined Modality Therapy; D005792:General Practice, Dental; D006801:Humans; D007347:Insurance, Dental; D010517:Periodontics; D010518:Periodontitis / Q000175:diagnosis / Q000382:microbiology / Q000628:therapy*; D013039:Specialties, Dental
D000900:Anti-Bacterial Agents; D001587:Benzoylarginine-2-Naphthylamide